Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

PHASE3CompletedINTERVENTIONAL
Enrollment

820

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

August 31, 2015

Conditions
Chronic Hepatitis B
Interventions
DRUG

Ypeginterferon alfa-2b

sc, qw, 48 weeks.

DRUG

Pegasys

sc, qw, 48 weeks.

Trial Locations (43)

361000

Xiamen Hospital of T.C.M, Xiamen

518036

Beijing University Shenzhen Hospital, Shenzhen

Unknown

302 Military Hospital, Beijing

Beijing Ditan Hospital Capital Medical University, Beijing

Beijing Youan Hospital, Capital Medical University, Beijing

Beijing Youyi Hospital, Capital Medical University, Beijing

Peking University First Hospital, Beijing

Peking University People's Hospital, Beijing

First Affiliated Hospital of Jilin University, Changchun

Xiangya Hospital, Central-south University, Changsha

Xiangya Second Hospital, Central-south University, Changsha

West China Hospital, Sichuan University, Chengdu

Second Affiliated Hospital Chongqing Medical University, Chongqing

Southwest Hospital, Chongqing

Fuzhou Infectious Disease Hospital, Fuzhou

Guangzhou Eighth People's Hospital, Guangzhou

Nanfang Hospital, Guangzhou

First Affiliated Hospital of Guangxi Medical University, Guilin

First Affiliated Hospital, Zhejiang University, Hangzhou

Second Affiliated Hospital of Harbin Medical University, Harbin

Jinan Infectious Disease Hospital, Jinan

First Affiliated Hospital of Lanzhou University, Lanzhou

81 Military Hospital, Nanchang

First Affiliated Hospital of Nanchang University, Nanchang

Jiangsu Province Hospital, Nanjing

Second Hospital of Nanjing, Nanjing

85 Military Hospital, Shanghai

Huashan Hospital, Shanghai

Ruijing Hospital, Shanghai

Shanghai Public Health Clinical Center, Shanghai

Shengjing Hospital of China Medical University, Shenyang

Shenyang Sixed People's Hospital, Shenyang

Third Affiliated Hospital, Hebei Medical University, Shijiazhuang

First Affiliated Hospital, Shanxi University, Taiyuan

Tianjin Third Central Hospital, Tianjin

First Affiliated Hospital of Xinjiang Medical University, Ürümqi

First Affiliated Hospital of Wenzhou Medical College, Wenzhou

Tongji Hospital, Huazhong University of Science & Technology, Wuhan

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan

Tangdu Hospital, Fourth Military Medical University, Xi'an

Xijing Hospital, Xi'an

The First Affiliated Hospital of Xiamen University, Xiamen

Henan Provincial People's Hospital, Zhengzhou

All Listed Sponsors
collaborator

Peking University First Hospital

OTHER

lead

Xiamen Amoytop Biotech Co., Ltd.

INDUSTRY

NCT01760122 - Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B | Biotech Hunter | Biotech Hunter